Houlihan Lokey Advises Genysis

Houlihan Lokey is pleased to announce the sale of Genysis Brand Solutions (Genysis) to Nellson Nutraceutical, LLC (Nellson), a portfolio company of Kohlberg & Company, LLC (Kohlberg). The transaction closed on December 4, 2017.

Founded in 2003 and headquartered in Salt Lake City, Utah, Genysis is a premier producer of powdered nutritional supplements in North America. Genysis offers its customers a diverse base of products and is recognized in the industry for exceptional quality, consistency, and reliability of service. In addition, the company places a strong emphasis on R&D, with tremendous institutional knowledge based on more than 10 years of functional powder manufacturing expertise. Genysis operates a Salt Lake City facility comprised of more than 300,000 square feet of production and warehouse space.

Nellson, the leading full-service nutritional bar and powder provider in North America, is based in Anaheim, California, with production locations in California and Quebec, Canada. Founded in 1962, Nellson has more than 50 years of diversified expertise in nutrition platforms for bars and powders, serving the nutrition, performance, weight management, snack/breakfast, and functional market segments. Nellson offers technical capabilities, quality assurance, flexible production, research and development, and sales and marketing support.

Kohlberg is a leading private equity firm specializing in middle-market investing. Since its inception in 1987, Kohlberg has organized eight private equity funds, through which it has raised more than $7.5 billion of committed equity capital. Over its 30-year history, Kohlberg has completed 72 platform investments and more than 162 add-on acquisitions, with an aggregate transaction value of more than $15 billion.

Houlihan Lokey served as the exclusive financial advisor to Genysis and assisted in structuring and negotiating the transaction on its behalf.

RELATED: Consumer, Financial Sponsors Coverage